Taxanes in the Treatment of Advanced Gastric Cancer

被引：16

作者：

Kang, Byung Woog ^{[1
]}

Kwon, Oh-Kyoung ^{[2
]}

Chung, Ho Young ^{[2
]}

Yu, Wansik ^{[2
]}

Kim, Jong Gwang ^{[1
]}

机构：

[1] Kyungpook Natl Univ, Dept Oncol Hematol, Med Ctr, Sch Med,Canc Res Inst, 807 Hogukno, Daegu 41404, South Korea

[2] Kyungpook Natl Univ, Dept Surg, Kyungpook Natl Univ Hosp, Sch Med, Daegu 41494, South Korea

来源：

MOLECULES | 2016年 / 21卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

gastric cancer; taxanes; paclitaxel; docetaxel; chemotherapy; PHASE-III TRIAL; ALBUMIN-BOUND PACLITAXEL; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; PLUS CISPLATIN; ANTITUMOR-ACTIVITY; OPEN-LABEL; FLUOROURACIL; DOCETAXEL; ADENOCARCINOMA;

D O I：

10.3390/molecules21050651

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first-or second-line chemotherapy setting for AGC.

引用

页数：10

共 50 条

[1] Influence of Taxanes on Treatment Sequence in Gastric Cancer
Lorenzen, Sylvie
Stahl, Michael
Hofheinz, Ralf-Dieter
Al-Batran, Salah-Eddin
Lordick, Florian
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (1-2) : 42 - 47
[2] The treatment of advanced gastric cancer: New findings on the activity of the taxanes
Van Cutsem, E
ONCOLOGIST, 2004, 9 : 9 - 15
[3] Recent advances in chemotherapy for advanced gastric cancer
Kim, Jong Gwang
Chung, Ho Young
Yu, Wansik
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (07) : 287 - 294
[4] Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
Shitara, Kohei
Matsuo, Keitaro
Mizota, Ayako
Kondo, Chihiro
Nomura, Motoo
Takahari, Daisuke
Yokota, Tomoya
Ura, Takashi
Ito, Seiji
Sawaki, Akira
Tajika, Masahiro
Kawai, Hiroki
Muro, Kei
GASTRIC CANCER, 2011, 14 (02) : 155 - 160
[5] Role of taxanes in advanced prostate cancer
Cassinello, J.
Carballido Rodriguez, J.
Anton Aparicio, L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (10) : 972 - 980
[6] Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer
Sasaki, Akinori
Kawazoe, Akihito
Eto, Testuya
Okunaka, Mashiro
Mishima, Saori
Sawada, Kentaro
Nakamura, Yoshiaki
Kotani, Daisuke
Kuboki, Yasutoshi
Taniguchi, Hiroya
Kojima, Takashi
Doi, Toshihiko
Yoshino, Takayuki
Akimoto, Tetsuo
Shitara, Kohei
ESMO OPEN, 2019, 4 (SUPPL_2)
[7] Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer
Ma, Xiaoting
Zhang, Yujian
Wang, Cong
Yu, Jing
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 381 - 396
[8] Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center
Sirohi, Bhawna
Rastogi, Sameer
Dawood, Shaheenah
Talole, S.
Ramadwar, Mukta
Shetty, Nitin
Shrikhande, Shailesh V.
MEDICAL ONCOLOGY, 2014, 31 (10) : 1 - 8
[9] Recent advances in chemotherapy for advanced gastric cancer in Japan
Fujii, Masashi
Kochi, Mitsugu
Takayama, Tadatoshi
SURGERY TODAY, 2010, 40 (04) : 295 - 300
[10] Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination
Fujiwara, Yoshiyuki
Takiguchi, Shuji
Nakajima, Kiyokazu
Miyata, Hiroshi
Yamasaki, Makoto
Kurokawa, Yukinori
Mori, Masaki
Doki, Yuichiro
JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (01) : 38 - 42

← 1 2 3 4 5 →